View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
April 2, 2020

EMA advises malaria drugs use for trials only; FDA records shortage

The European Medicines Agency (EMA) has urged that two malaria drugs, chloroquine and hydroxychloroquine, being tested as potential Covid-19 treatment, must only be used for clinical trials or national emergency use programmes.

Separately, the US Food and Drug Administration (FDA) said that these drugs are in shortage due to increased demand amid the Covid-19 pandemic.

Read the full article here

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU